Sina Samie, MD
Anesthesiology · Los Angeles, CANPI 1992191514
Payments from drug & device makers
Across 107 payments — averaging $76.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$3K
- Boston Scientific$3K
- Biohaven Pharmaceuticals, Inc.$1K
- Abbott$815
- AbbVie$195
- Relievant Medsystems, Inc.$179
- plus $436 from 12 others
What the payments were for
- Consulting fees$1,20015%
- Travel & lodging$1,79022%
- Food & beverage$5,21264%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 26 | $2,708 |
| Boston Scientific | 42 | $2,669 |
| Biohaven Pharmaceuticals, Inc. | 1 | $1,200 |
| Abbott | 13 | $815 |
| AbbVie(2 entities) | 4 | $195 |
| Relievant Medsystems, Inc. | 2 | $179 |
| Stryker | 3 | $65 |
| Vertos Medical, Inc. | 1 | $61 |
| Novartis | 3 | $60 |
| Amgen | 3 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Vertex | 1 | $34 |
| Nalu Medical, Inc. | 1 | $30 |
| Curonix LLC | 1 | $26 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| AstraZeneca | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$1,827
- NURTEC ODT$1,200
- SUPERION$991
- Intracept$634
- PROCLAIM$276
- GENERAL PAIN MANAGEMENT$256
- SPECTRA WAVEWRITER$235
- Proclaim IPG$156
- ETERNA$147
- BOTOX$129
How this compares
$8,203 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 1,090 | $11,886 |
| Pregabalin | 322 | $6,618 |
| Duloxetine Hcl | 201 | $6,293 |
| Diclofenac Sodium | 239 | $5,422 |
| Lidocaine | 31 | $5,063 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 207 | $3,774 |
| Buprenorphine | 11 | $3,077 |
| Celecoxib | 27 | $2,509 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $1,503 |
| Baclofen | 140 | $1,475 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 83 | $1,097 |
| Cyclobenzaprine Hcl | 153 | $1,065 |
| Tramadol Hcl | 230 | $1,056 |
| Methocarbamol | 65 | $842 |
| Tizanidine Hcl | 45 | $395 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Los Angeles
- Eilon GabelLos Angeles$1.2M
- Maxime CannessonLos Angeles$759K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Anahat DhillonLos Angeles$184K
- Michael BottrosLos Angeles$182K
- David BoldtLos Angeles$153K
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.